Role of the clinical pharmacist in detection of drug therapy problemas in critically impatients: experience report

Página do item simplificado
dc.contributor.authorAlves, Gabrielle Mari Rosetti [UNESP]
dc.contributor.authorVarallo, Fabiana Rossi [UNESP]
dc.contributor.authorLucchetta, Rosa Camila
dc.contributor.authorMastroianni, Patricia de Carvalho [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade Federal do Paraná (UFPR)
dc.date.accessioned2016-01-28T16:56:26Z
dc.date.available2016-01-28T16:56:26Z
dc.date.issued2014
dc.description.abstractThis is an experience report on clinical pharmacy in New York, United States of America, in a teaching hospital, describing the results of drug therapy monitoring in critically ill patients, as well as interventions to solve or prevent identified drug therapy problems. The cross-sectional study was conducted by the clinical staff at the Surgical Intensive Care Unit during August 20th to 24th, 2012. Blood counts, serum levels of certain antibiotics, microbiological cultures and their antibiotic susceptibility, possible drug interactions, dosage of each drug prescribed and the compatibility between the route of administration and pharmaceutical form were assessed daily through review of electronic medical records. Twenty seven patients were followed up and 16 drug therapy problems were identified: Unnecessary drug therapy (seven), adverse drug reaction (four), needs additional drug therapy (two), noncompliance (two) and dosage too low (one). After evaluation, the drug therapy problems and their pharmaceutical interventions were reported to clinical pharmaceutical responsible for the Surgical ICU, as well as the multidisciplinary team. Further, the clinical outcomes were monitored and interventions were classified as to its acceptance. Data demonstrate that clinical pharmacists can contribute to the security and proper use of medications, as the trigger tools for intensive monitoring helps in early detection of drug therapy problems and patient safety.en
dc.description.affiliationUniversidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Ciências Farmacêuticas de Araraquara, Araraquara, Rodovia Araraquara/Jaú Km 1, Campus, CEP 14801902, SP, Brasil
dc.description.affiliationPharmacy Department of Universidade Federal do Paraná (UFPR), Brazil
dc.description.affiliationUnespUniversidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Ciências Farmacêuticas de Araraquara, Departamento de Fármacos e Médicamentos, Araraquara, Rodovia Araraquara/Jaú Km 1, Campus, CEP 14801902, SP, Brasil
dc.format.extent1-6
dc.identifierhttp://esciencecentral.org/journals/role-of-the-clinical-pharmacist-in-detection-of-drug-therapy-problems-in-critically-inpatients-experience-report-2329-6887-2-139.php?aid=29742
dc.identifier.citationJournal of Phamacovigilance, v. 2, n. 4, p. 139, 2014.
dc.identifier.fileISSN2329-6887-2014-02-04-01-06.pdf
dc.identifier.issn2329-6887
dc.identifier.lattes4160558780902988
dc.identifier.orcid0000-0001-8467-7278
dc.identifier.urihttp://hdl.handle.net/11449/133741
dc.language.isoeng
dc.relation.ispartofJournal of Phamacovigilance
dc.rights.accessRightsAcesso aberto
dc.sourceCurrículo Lattes
dc.subjectPatient safetyen
dc.subjectPharmacovigilanceen
dc.subjectDrug-related side effects and adverse reactionsen
dc.subjectIntensive Care Unitsen
dc.titleRole of the clinical pharmacist in detection of drug therapy problemas in critically impatients: experience reporten
dc.typeArtigo
unesp.author.lattes4160558780902988[4]
unesp.author.orcid0000-0001-8467-7278[4]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentFármacos e Médicamentospt

Arquivos

Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
ISSN2329-6887-2014-02-04-01-06.pdf
Tamanho:
325.02 KB
Formato:
Adobe Portable Document Format
Baixar

Coleções

Artigos - Fármacos e Medicamentos - FCFAR